Analyst Ratings for Myriad Genetics Inc. (MYGN)

Updated: 2017-07-26

An average rating of Hold has been given to Myriad Genetics Inc. (NASDAQ:MYGN) by analysts covering the stock. MYGN had previously received a consensus rating of Hold a month ago.

15 analysts issued ratings on the stock, where 2 gave MYGN a buy rating, 0 issued an overweight rating, 9 gave a hold rating, 1 gave an underweight rating, and 3 gave a sell rating. Today, there are 0 more analysts optimistic about the company future as compared with 90 days ago. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Several price targets were given for MYGN by the analysts covering the stock. The most optimistic analyst gave a price target of 30, implying potential capital gains of 26.37 percent. The minimum price target given was 16, which equates to a potential downside of -32.6 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. The average change in earnings estimates over the last 90 days is -1.65 percent. Meanwhile, fiscal year estimates have been revised upwards by 0 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of 3.56 percent in FY estimates.

People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 0 analysts increased their quarterly estimates, while 0 analysts made negative revisions. Also over the last month, 2 analysts increased their estimates for the FY earnings, while 0 analysts decreased their estimates.

Analysts estimate earnings of MYGN to grow at a rate of 135.64 percent. People on Wall Street often look at a company's PEG ratio. Investors like to see smaller values for the PEG ratio, because people typically see that as an indicator of higher growth relative to stock price. Many investors consider PEG ratios between 0 and 1 as preferrable, although it is frequently more appropriate to compare PEG ratios to the company's peers. The PEG ratio of MYGN is 0.39.

MYGN has a 52-week high of 32.54 and a 52-week low of 15.15. Today's price is 56.7 percent above the 52-week low, and 27.04 percent lower than its 52-week high. MYGN has a price/earnings ratio of 52.76. Investors typically compare the P/E ratio to a company's peers in the industry. The MYGN value stock report compares MYGN to some of its peers using value stock charts. The market cap of MYGN is $1.63 billion. MYGN is estimated to release their earnings results for the quarter on 0000-00-00, days from today.